Evaluation of ceftiofur-PHBV microparticles in rats
Autor
Vilos C.
Constandil L.
Rodas P.I.
Cantin M.
Zepeda K.
Herrera N.
Velasquez L.A.
Resumen
Despite the high number of antibiotics used for the treatment of infectious disease in animals, the development of slow release formulations presents a significant challenge, particularly in using novel biomaterials with low cost. In this report, we studied the pharmacokinetics, toxicity, and therapeutic activity of ceftiofur-PHBV (ceftiofur-poly(3-hydroxybutyrate-co-3-hydroxyvalerate)) in rats. The pharmacokinetic study demonstrated a sustained release of ceftiofur into the bloodstream, with detectable levels over the minimum inhibitory concentration for at least 17 days after a single intramuscular injection of ceftiofur-PHBV (10 mg/kg weight). In addition, the toxicological evaluation of biochemical, hematological, and coagulation blood parameters at the therapeutic dose demonstrated the safety of ceftiofur-PHBV, with no adverse effects. In addition, ceftiofur-PHBV exhibited a therapeutic effect for a longer time period than the nonencapsulated ceftiofur in rats challenged with Salmonella Typhimurium. The slow release of ceftiofur from the ceftiofur-PHBV, its low toxicity in the blood parameters evaluated, and the efficacy in the rats infected with Salmonella Typhimurium make ceftiofur-PHBV a strong candidate for biotechnological applications in the veterinary industry. © 2014 Vilos et al.
Colecciones
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Article
Inhibition of C. albicans dimorphic switch by cobalt(II) complexes with ligands derived from pyrazoles and dinitrobenzoate: Synthesis, characterization and biological activity (2020)
Fonseca D.; Leal-Pinto S.M.; Roa-Cordero M.V.; Vargas J.D.; Moreno-Moreno E.M.; Macías M.A.; Suescun L.; Muñoz-Castro Á.; Hurtado J.J. (MDPI AG, 2019) -
Article
Antifungal toxicity of linear geranylphenol. Influence of oxigenate substituents (2020)
Taborga L.; Sortino M.; Carrasco H.; Butassi E.; Zacchino S.; Espinoza L. (Elsevier Ltd, 2017) -
Article
Synthesis and structure-activity relationship study of novel 3-heteroarylcoumarins based on pyridazine scaffold as selective MAO-B inhibitors (2020)
Costas-Lago M.C.; Besada P.; Rodríguez-Enríquez F.; Viña D.; Vilar S.; Uriarte E.; Borges F.; Terán C. (Elsevier Masson SAS, 2017)